Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide

Jakob Schöllhammer Knudsen, Reimar Wernich Thomsen, Anton Pottegård, Filip Krag Knop, Henrik Toft Sørensen

Research output: Contribution to journalJournal articleResearchpeer-review

114 Downloads (Pure)
Original languageEnglish
JournalDiabetes Care
Volume41
Issue number9
Pages (from-to)e133-e135
ISSN1733-5671
DOIs
Publication statusPublished - 1. Sep 2018

Cite this